Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery

Tumour necrosis factor (TNF)-based isolated limb perfusion (ILP) is an approved and registered treatment for sarcomas confined to the limbs in Europe since 1998, with limb salvage indexes of 76%. TNF improves drug distribution in solid tumours and secondarily destroys the tumour-associated vasculatu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Brunstein, F, Rens, J, van Tiel, S T, Eggermont, A M M, ten Hagen, T L M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2006
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360755/
https://ncbi.nlm.nih.gov/pubmed/17106443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603461
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados